Medical Specialty >> Oncology
Medicaid Coverage for Lung Cancer Screening All Over the Map
2:00 PM CDT.
Read article
- Could the U.S. Mail Deliver Better Colon Cancer Screening Rates?
- Baby Monkey May Offer Hope to Preserving Fertility of Kids With Cancer
- Drug Combo Does Double Duty Against Common Skin Lesions, Cancers
- Walk, Dance, Clean: Even a Little Activity Helps You Live Longer
JOURNAL UPDATE
Topical Immunotx for Actinic Keratosis May Prevent Cancer
12:00 PM CDT. Fewer patients treated with calcipotriol plus 5-FU developed SCC on treated face, scalp within three…- Low, High Levels of Physical Activity Tied to Reduced Mortality
- State Breast Density Notification Laws May Up Ultrasound Use
- Digital Breast Tomosynthesis Can Reduce Benign Biopsy Rate
MONTHLY JOURNAL SUMMARY
February 2019 Briefing - Hematology & Oncology
March 01, 2019. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial
Robert L. Coleman, MD.
Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…
Characterization of patients with ovarian carcinoma who respond to the PARP inhibitor rucaparib
Elizabeth M. Swisher, MD.
Dr. Elizabeth M. Swisher comments on the implications of new data from the ARIEL2 trial, an ongoing Phase 2 trial of the novel PARP inhibitor rucaparib in relapsed, high-grade serous or endometrioid ovarian cancer. The new results offer an important insight into the genetic mechanisms behind tumor sensitivity…
Bert Vogelstein explains cancer and the unavoidable replicative mutations
Bert Vogelstein, MD.
Investigators at Johns Hopkins University in Baltimore used complex mathematical modeling to track mutations driving abnormal cell growth for 32 types of cancer. From their calculations, the researchers believe that the bulk of cancers are caused by random DNA copying errors (replicative mutations).…
MEDICAL FOCUS
Breast cancer
By Tamer M. Fouad, M.D. Breast cancer is a cancer that starts in the cells of the breast. Worldwide, breast cancer is the second most common type of cancer after lung cancer (11.9%…
DISCUSSION
RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
By MrRobinGreat articles. learnt a lot from it.
